serial measurements of cerebral hemodynamics. The study was approved by the Institutional Review Board of the Baylor College of Medicine.
Upon arrival in the emergency room, patients immediately underwent intubation, hemodynamic stabilization, and resuscitation when necessary. Patients in whom an intracranial mass lesion was demonstrated on the initial CT evaluation underwent an immediate neurosurgical procedure. The ICP, blood pressure, SjvO 2 , and PbtO 2 were monitored in all patients during the acute postinjury period. The goals of the early management were ICP Ͻ 20 mm Hg and CPP Ͼ 60 mm Hg, unless the SjvO 2 value indicated that a higher level of CPP was needed. A stable Xe-CT measurement of CBF was obtained when the patient was physiologically stable.
Measurement of PbtO 2
The PbtO 2 was measured continuously in all 83 patients by using a miniaturized Clark-type electrode PO 2 catheter (LICOX; GMSmbH). Alongside the PbtO 2 probe, a temperature probe was placed in the cortex, and both were connected to the monitor for automatic temperature-corrected PbtO 2 readings. The position of the PbtO 2 probe in the brain was assessed by obtaining follow-up CT scans. In 20 cases, the probe was located in normal-appearing brain, in 35 it was located near a contusion, and in the remaining 28 cases it was placed in abnormal-appearing brain following removal of a subdural hematoma. The PbtO 2 values were continuously collected at 30-second intervals and stored in a computer. At the end of the monitoring period the PbtO 2 probes were removed and calibration drift was determined by measuring stable PO 2 in a 0% O 2 solution, in a Level I arterial blood gas control solution (Ciba-Corning Diagnostics Corp.), and in room air. Only data from PO 2 catheters that remained correctly calibrated were used in this study.
Measurement With Xe-CT Scanning
All CBF studies were performed with a CT scanner (CTI; General Electric Medical Systems) equipped with a stable xenon gas delivery system. The CBF studies were obtained as clinically indicated. The mean time at which studies were performed was 30.5 Ϯ 3.6 hours postinjury. All values presented this way are expressed as the mean Ϯ standard deviation.
For the calculation of CBF, the Xe-CT System 2 (Diversified Diagnostic Products) was used. Blood flow determinations were made based on findings in 4 CT scan slices that were 10 mm thick and separated by 15 mm. For comparison with the PbtO 2 values, rCBF was determined in a 2-cm circular region of interest on the CT slice that pictured the tip of the PO 2 catheter (the region of interest was centered around the tip of the catheter).
Measurement of O 2 Reactivity
Serial measurements of O 2 reactivity were performed during a period of 7 days after the injury. The measurements were performed every 12 hours during the first 5 days and on a daily basis thereafter. Arterial and jugular venous blood gas values were obtained during baseline and during the period of hyperoxia induced by increasing FiO 2 to 1.0. Equilibration for at least 10 minutes was allowed during the period of hyperoxia. The O 2 reactivity was calculated using the following formula: change in PbtO 2 ϫ 100/change in PaO 2 . For comparison with the Xe-CT data, the O 2 reactivity test at the time of the CBF measurement was used in the analysis. The mean time between the O 2 reactivity test and the CBF measurement was 3.1 Ϯ 0.9 hours.
Statistical Analysis
The changes in the physiological variables after induction of hyperoxia were analyzed using the paired t-test. The effect of the CBF level on the values of the physiological variables at the baseline PaO 2 and on the change in these values with hyperoxia was analyzed using analysis of variance.
Results

Patient Demographics
The patients' characteristics were typical for a severely head-injured population, with a predominance of males (83%) and a mean initial GCS score of 6.2 Ϯ 3.1 (Table 1) . Prehospital hypoxic events occurred in one third of patients. Initial head CT scans revealed evacuated mass lesion in 43 patients (52%) based on the Marshall CT classification. 11 Outcome characteristics are presented in Table 2 . At 6 months after the TBI, data were available for 73 patients, with a mortality rate of 31% and good outcome in 33% of patients. Figure 1 shows an example of the changes in middle cerebral artery FV, SjvO 2 , and PbtO 2 that occur with hyperoxia induced by breathing 100% O 2 . The PbtO 2 and SjvO 2 rapidly increase, and middle cerebral artery FV decreases by a small amount. As the SjvO 2 increases in this example from 63 to 75%, the PjvO 2 increases from 35 to 43 mm Hg. The observed increase in PjvO 2 is considerably less than the 122-mm Hg change that occurred in the PbtO 2 .
Physiological Changes With Hyperoxia
The average changes for these physiological variables for the entire group of patients are illustrated in Fig. 2 . There were significant increases in PbtO 2 and PjvO 2 ; however, the PbtO 2 changes were consistently larger than those in PjvO 2 . There were small but significant decreases in ICP, middle cerebral artery FV, and ETCO 2 during hyperoxia. No significant changes were measured in mean blood pressure or in PaCO 2 .
The PbtO 2 at baseline PO 2 (FiO 2 0.3-0.4) was significantly correlated with the rCBF at the probe site (r = 0.69, p Ͻ 0.001). Furthermore, the change in PbtO 2 with hyperoxia was correlated with baseline PbtO 2 and with rCBF at the probe site (r = 0.44 and r = 0.33, respectively).
To further examine this relationship between blood flow and O 2 reactivity, the patients were divided into 5 groups based on the level of the rCBF. The blood flow thresholds for these groups were assigned empirically based on the following considerations. A cortical blood flow Ͻ 10 ml/ 100 g/min has been associated with infarction. A cortical blood flow between 11 and 20 ml/100 g/min is considered penumbral flow, and this was divided into 2 categories, 11-15 ml/100 g/min and 16-20 ml/100 g/min. A CBF between 21 and 40 ml/100 g/min is abnormally low but does not generally result in clinical findings. A CBF Ͼ 40 ml/ 100 g/min is normal cortical flow. As shown in Fig. 3 , the baseline PbtO 2 closely followed the rCBF values, increasing from 4.9 Ϯ 6.7 mm Hg when the rCBF was Ͻ 10 ml/ 100 g/min to 31.0 Ϯ 17.9 ml/100 g/min when the rCBF was normal. Similarly, the O 2 reactivity increased from 0.6 Ϯ 1.1 mm Hg when rCBF was Ͻ 10 ml/100 g/min to 17.5 Ϯ 14.1 when the rCBF was normal. Hypoxia-induced changes in the other physiological variables had no relationship to the CBF group (Table 3) .
Discussion
Several factors determine the value for PbtO 2 as measured with the PO 2 probes that are available for clinical use. Cerebral blood flow in the area of the brain around the probe is certainly one of these factors. The relationship of the PbtO 2 value to global CBF depends on how representative of global CBF the tissue at the probe site is. In the current study, the probes were often placed in tissue in which the local PO 2 was of interest. For this reason, there was not a close correlation between the PbtO 2 value and the average cortical CBF. There was a good correlation, however, between the baseline PbtO 2 and rCBF at the site of the PO 2 probe. These findings are consistent with those in previous clinical studies in which stable Xe-CT scanning was used for assessment of CBF, showing a correlation between PbtO 2 and CBF. 16, 23 The PaO 2 is another factor that determines the PbtO 2 . The relative effect of PaO 2 on PbtO 2 varies by patient and also over time in the same patient. Several investigators have examined factors that might be responsible for this variability. Meixensberger et al.
14 observed that the increase in PbtO 2 with hyperoxia was much greater in pathological tissue than in normal brain tissue. Longhi et al. 9 found that the increase in PbtO 2 with hyperoxia was small (average 0.8 mm Hg/min/100 mg PaO 2 ) when PbtO 2 was low (average 19.7 Ϯ 13.1 mm Hg), compared with 8 mm Hg/min/ 100 mg PaO 2 when PbtO 2 was higher (average 31.7 Ϯ 14.3 mm Hg). Sarrafzadeh et al. 19 similarly observed that hyperoxia only increased PbtO 2 when the catheter was placed in pericontusional and nonlesioned brain. When the catheter was placed in contused brain, little increase in PbtO 2 occurred with hyperoxia. Using bilateral PO 2 catheters, Kiening et al. 7 made similar observations. Based on the results in our study, we suggest that the CBF level at the site of the PO 2 probe might explain these observations. 
Physiological Effects of Hyperoxia
The physiological effects of hyperoxia in patients with TBI are similar to those observed in normal controls. There was a small decrease in ETCO 2 and a similar small decrease in blood flow, as measured with transcranial Doppler FV. The decrease in CBF after induction of hyperoxia in normal volunteers ranges from 13 to 32%, depending on the method used to measure CBF. 4, 6, 8, 18, 25 Some have assumed that the decrease in blood flow during hyperoxia is induced by the decrease in ETCO 2 . However, Floyd et al. 4 have shown that there is an independent effect of hyperoxia on CBF that is not accounted for by the change in ETCO 2 .
It cannot be excluded, however, that a decrease in ETCO 2 may also contribute to the decrease in CBF observed in patients with hyperoxia. The magnitude of the change in FV that occurred in the patients with TBI was smaller than the change in CBF observed in these studies of normal controls. However, the actual change in PaO 2 was also probably smaller in the patients with TBI because their baseline FiO 2 was 0.3-0.4 compared with room air.
The small decrease in ICP observed in patients with hyperoxia, like the decrease in FV, is probably due to the vasoconstricting effects of hyperoxia and/or the small decrease in ETCO 2 caused by breathing 100% O 2 . Tolias et al. 21 observed an average 3-mm Hg decrease in ICP with hyperoxia in patients with severe TBI, similar in magnitude to the findings in the present study.
Clinical Implications of Hyperoxia Findings
Because PbtO 2 increases significantly during hyperoxia, and because induction of hyperoxia is a simple therapeutic intervention, it has been proposed as a possible treatment for brain ischemia. Nevertheless, the relatively small increase in PaO 2 content induced by hyperoxia does not increase O 2 delivery much, especially when CBF is low, and the effectiveness of hyperoxia as a therapeutic intervention remains controversial.
Experimental studies are divided in their findings regarding neuroprotective effects of hyperoxia. Some studies support the suggestion that hyperoxia after TBI may increase oxidative damage. In other models of TBI, normobaric hyperoxia has been noted to have neuroprotective effects. 1, 17 Likewise, in some clinical studies, investigators have observed improvement in brain metabolism (increased glucose levels and decreased lactate and lactate:pyruvate ratio) measured using microdialysis when hyperoxia is applied early after injury. 21 Others have reported that hyperoxia results in decreased lactate levels but no change in the lactate:pyruvate ratio.
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Conclusions
The findings in this study emphasize that when CBF is very low, the increase in PbtO 2 with hyperoxia is also very small. Although it cannot be excluded that even a small increase in O 2 delivery provided by hyperoxia might be important for tissue survival when CBF is very low, it is likely that therapeutic efforts to improve CBF would be more effective than hyperoxia at improving O 2 delivery.
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